IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Socma Testifies on Risks Involving Pharma Ingredient Imports

2:40 PM MST | November 7, 2007 | Chemical Week Editorial Staff

Socma’s bulk pharmaceutical task force chief John Dubeck testified last week at a House Energy & Commerce Committee’s subcommittee on oversight and investigation about risks associated with drugs imported into the U.S. There is a lack of government inspections of overseas facilities manufacturing active pharma ingredients (APIs) that go into drugs, Dubeck says. The majority of overseas facilities manufacturing APIs used in generic medications rarely see an FDA inspector after an initial inspection, and most overseas manufacturers of...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa